ALKERMES | ALKS - Процентный доход





Процентный доход Изменить Дата
AbbVie USD 72M 13M 2026-03
Acadia Pharmaceuticals USD 8.06M 277K 2026-03
ALKERMES USD 8.54M 3.59M 2026-03
Biogen USD 25.3M 12.6M 2026-06
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 45M 50M 2026-06
Heron Therapeutics USD 433K 277K 2021-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 0.09 2.18 2026-09
Merck USD 35M 34M 2026-03
Nektar Therapeutics USD -0.18 0.07 2024-09
Otsuka Holdings JPY 10.49B 396M 2024-06
Pfizer USD -0.04 115M 2026-06
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06